Cargando…
Sequential therapy with induction chemotherapy and chemoradiotherapy in pre-irradiated recurrent head and neck squamous cell carcinoma incorporating nab-paclitaxel—a commentary of the phase I trial of AFHX followed by concomitant FHX scheme
Autores principales: | Martinez-Trufero, Javier, Comin Orce, Ana, Gomez Mugarza, Pablo, Barriendos Sanz, Susana, Ortega Izquierdo, Eugenia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174998/ https://www.ncbi.nlm.nih.gov/pubmed/37180677 http://dx.doi.org/10.21037/tcr-23-131 |
Ejemplares similares
-
nab-Paclitaxel for the treatment of pancreatic cancer
por: Kim, George
Publicado: (2017) -
Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel
por: Kokubu, Hiraku, et al.
Publicado: (2023) -
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors
por: Martin-Broto, Javier, et al.
Publicado: (2022) -
Efficacy and safety of nab-paclitaxel or combined nab-paclitaxel and immune checkpoint inhibitors in relapsed small-cell lung cancer
por: Wan, Rui, et al.
Publicado: (2023) -
The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer
por: Takada, Ryoji, et al.
Publicado: (2021)